Journal of Advanced Research in Health Sciences

SUBMITINFORMATION
EnglishTürkçe

Review


DOI :10.26650/JARHS2020-S1-0006   IUP :10.26650/JARHS2020-S1-0006    Full Text (PDF)

COVID-19 and Hemophagocytic Lymphohistiocytosis

Ömer Devecioğlu

COVID-19 disease ,which has been seen first, in City Wuhan of Hubei Province of China ,with it’s etiology,contamination route and treatment options continues to being the main topic of the World. Because of it’s severe form ,necessitating intensive care facilities, COVID-19 disease is the main subject of different investigations. During the course of COVID-19 infection, symptoms of macrophage activation syndrome/secondary Hemophagocytic Lymphohistiotosis (MAS/sHLH) may develop, characterized by cytokin storm due to excessive inflammatory response. In this article the relation of COVID-19 diasease with Hemophagocytic Lymphohistiocytosis is discussed.

Keywords: COVID-19, HLH, Cytokine storm
DOI :10.26650/JARHS2020-S1-0006   IUP :10.26650/JARHS2020-S1-0006    Full Text (PDF)

COVID-19 ve Hemofagositik Lenfohistiyositoz

Ömer Devecioğlu

Ocak 2020 başından beri önce Çin’in Hubei Eyaleti Wuhan Kentinde ortaya çıkan ve COVID-19 diye adlandırılan hastalık, nedeni, bulaşma şekli ve tedavi seçenekleri ile dünya kamuoyunu yoğun bir şekilde meşgul etmektedir.Yüzde 20 oranında ciddi seyreden hastalıkta, mortalite %2-3 civarındadır. Ancak bu hastalık son döneminde yoğun bakım şartları gerektiren ağır formu nedeniyle yoğun araştırma konusudur. COVID-19 enfeksiyonun seyri sırasında aşırı enflamatuvar yanıta bağlı sitokin fırtınası ile karakterize makrofaj aktivasyonu sendromu/sekonder Hemofagositik Lenfohistiyotoz (MAS/sHLH) bulguları gelişebilir. Bu makalede COVID-19 hastalığının HLH ile olan ilişkisi derlenmiştir

Keywords: COVID-19, HLH, Sitokin fırtınası

PDF View

References

  • 1. Zhu N, Zhang D, Wang W Li X, Yang B, Song J ;et al. A Novel Coronavirus from Patients with Pneumonia in China,2019.N Eng J Med 2020;382(8):727-33. doi: 10.1056/ NEJMoa2001017. google scholar
  • 2. World Health Organization Press Conference. The World Health Organization (WHO) Has Officially Named the Disease Caused by the Coronvirus as COVID-19. Available online: https://www.who.int/emergencies/Novelcoronavirus-2019(accessed on 11 February 2020. google scholar
  • 3. Gorbalenya AE, Baker SC, Baric RC, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv February 11, 2020. doi: https://doi. org/10.1101/2020.02.07.937862 google scholar
  • 4. Jin Y, Yung H, Ji W, Wu W, Chen S, Zang W. et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020 Mar 27;12(4). pii: E372. doi: 10.3390/v12040372.. google scholar
  • 5. T.C Sağlık Bakanlığı ,Halk Sağlığı Genel Müdürlüğü ,COVİD-19 (SARS – CoV2) Enfeksiyon Rehberi, 25 Mart 2020. google scholar
  • 6. Mason RJ. Pathogenesis of COVID-19 from a cell biologic perspective. Eur Respir J 2020 Apr 9 : 2000607. doi: 10.1183/13993003.00607-2020 [Epub ahead of print] google scholar
  • 7. Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM; et al. Targeting potential drivers of COVİD19:Neutrophil extracellular traps J.Exp.Med 2020;217(6). pii: e20200652. doi: 10.1084/ jem.20200652. google scholar
  • 8. Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood 2020;135(16):1332-43. google scholar
  • 9. Mehta P, Mc Auley DF, Brown M, Sanchez E, Tottersall RS, Manson JJ., et al.COVİD-19 :consider cytokine storm syndromes and immunusupression. Lancet 2020;395(100229):1033-4. google scholar
  • 10. Apak Belen FB, Sarialioğlu F. The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases? Medical Hypoteses 2020 Sep;142: 109743. doi: 10.1016/j. mehy.2020.109743 google scholar
  • 11. Mc Gonagle D,Sharif K, O’Regan A, Bridgewood C. The role of cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev. 2020 Apr 3: 102537. doi: 10.1016/j.autrev.2020.102537. [Epub ahead of print] google scholar
  • 12. Richardson P, Aggarwal S, Topaloglu O, F.Villa K, Corbacioglu S. Systematic review of defibrotide studies in the treatment of veno-occlusive disease/ sinusoidal obstruction syndrome (VOD/SOS) . Bone Marrow Transplant. 2019;54(12):1951-62. doi: 10.1038/s41409-019-0474-8. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Devecioğlu, Ö. (2020). COVID-19 and Hemophagocytic Lymphohistiocytosis. Journal of Advanced Research in Health Sciences, 3(1), 49-52. https://doi.org/10.26650/JARHS2020-S1-0006


AMA

Devecioğlu Ö. COVID-19 and Hemophagocytic Lymphohistiocytosis. Journal of Advanced Research in Health Sciences. 2020;3(1):49-52. https://doi.org/10.26650/JARHS2020-S1-0006


ABNT

Devecioğlu, Ö. COVID-19 and Hemophagocytic Lymphohistiocytosis. Journal of Advanced Research in Health Sciences, [Publisher Location], v. 3, n. 1, p. 49-52, 2020.


Chicago: Author-Date Style

Devecioğlu, Ömer,. 2020. “COVID-19 and Hemophagocytic Lymphohistiocytosis.” Journal of Advanced Research in Health Sciences 3, no. 1: 49-52. https://doi.org/10.26650/JARHS2020-S1-0006


Chicago: Humanities Style

Devecioğlu, Ömer,. “COVID-19 and Hemophagocytic Lymphohistiocytosis.” Journal of Advanced Research in Health Sciences 3, no. 1 (Apr. 2024): 49-52. https://doi.org/10.26650/JARHS2020-S1-0006


Harvard: Australian Style

Devecioğlu, Ö 2020, 'COVID-19 and Hemophagocytic Lymphohistiocytosis', Journal of Advanced Research in Health Sciences, vol. 3, no. 1, pp. 49-52, viewed 28 Apr. 2024, https://doi.org/10.26650/JARHS2020-S1-0006


Harvard: Author-Date Style

Devecioğlu, Ö. (2020) ‘COVID-19 and Hemophagocytic Lymphohistiocytosis’, Journal of Advanced Research in Health Sciences, 3(1), pp. 49-52. https://doi.org/10.26650/JARHS2020-S1-0006 (28 Apr. 2024).


MLA

Devecioğlu, Ömer,. “COVID-19 and Hemophagocytic Lymphohistiocytosis.” Journal of Advanced Research in Health Sciences, vol. 3, no. 1, 2020, pp. 49-52. [Database Container], https://doi.org/10.26650/JARHS2020-S1-0006


Vancouver

Devecioğlu Ö. COVID-19 and Hemophagocytic Lymphohistiocytosis. Journal of Advanced Research in Health Sciences [Internet]. 28 Apr. 2024 [cited 28 Apr. 2024];3(1):49-52. Available from: https://doi.org/10.26650/JARHS2020-S1-0006 doi: 10.26650/JARHS2020-S1-0006


ISNAD

Devecioğlu, Ömer. “COVID-19 and Hemophagocytic Lymphohistiocytosis”. Journal of Advanced Research in Health Sciences 3/1 (Apr. 2024): 49-52. https://doi.org/10.26650/JARHS2020-S1-0006



TIMELINE


Submitted30.04.2020
Accepted02.05.2020
Published Online15.05.2020

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.